The Asia Pacific Fibromyalgia Treatment Market would witness market growth of 5.2% CAGR during the forecast period (2023-2030).
Fibromyalgia (FM) is a somatization illness characterized by widespread, persistent musculoskeletal pain in addition to impacting the patient's quality of life. The symptoms also affect the patient's emotional condition because the only indication of the sickness is a pain in the whole body. Among the functional issues that frequently coexist with FM are depression, panic attacks, irritable bowel syndrome, chronic fatigue syndrome, anxiety, and post-traumatic stress disorder. Fibromyalgia is commonly categorized as a pain control disorder because it is a central sensitization problem.
FM is believed to be caused by sensitization, which encompasses systemic symptoms including cognitive decline, sleep issues, anxiety, tiredness, and depressive episodes, as well as central sensitivity syndromes like joint stiffness and chronic pain at multiple painful places. Many ailments, including infections, mental or neurological disorders, diabetes, and rheumatic pathologies, are usually connected to FM. Moreover, despite proof for a specific candidate gene, numerous studies have suggested a genetic predisposition for fibromyalgia.
The remarkable rise in human longevity throughout the 20th century has manifested in the region phenomenon of population aging. India's population over 60 has more than quadrupled in the past 50 years. According to the 2011 census, the number of elderly persons (60+ years) was 103.83 million; this number is expected to rise to 133.32 million in 2021, 178.59 million in 2031, 236.01 million in 2041, and 300.96 million in 2051. Considering that musculoskeletal disorders like fibromyalgia are typically more prevalent in the elderly, the growing geriatric population and the government's approach to ensuring the welfare of the elderly will increase the demand and purchasing power of the population in the region, thereby driving market growth in APAC.
The China market dominated the Asia Pacific Fibromyalgia Treatment Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $302.6 million by 2030. The Japan market is exhibiting a CAGR of 4.5% during (2023 - 2030). Additionally, The India market would register a CAGR of 5.8% during (2023 - 2030).
Based on Drug Class, the market is segmented into Anticonvulsants, Antidepressants, Muscle Relaxants and Others. Based on Distribution Channel, the market is segmented into Drug stores & Retail Pharmacies, Hospital Pharmacies and Online Providers. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Fibromyalgia Treatment Market is Projected to reach USD 4 Billion by 2030, at a CAGR of 4.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Novartis AG, Eli Lilly And Company, Amneal Pharmaceuticals, Inc., Teva Pharmaceuticals Industries Ltd., Zydus Lifesciences Ltd., Lupin Limited, Abbott Laboratories, Viatris, Inc., and Sun Pharmaceutical Industries Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Drug Class
- Anticonvulsants
- Antidepressants
- Muscle Relaxants
- Others
By Distribution Channel
- Drug stores & Retail Pharmacies
- Hospital Pharmacies
- Online Providers
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- AbbVie, Inc.
- Novartis AG
- Eli Lilly And Company
- Amneal Pharmaceuticals, Inc.
- Teva Pharmaceuticals Industries Ltd.
- Zydus Lifesciences Ltd.
- Lupin Limited
- Abbott Laboratories
- Viatris, Inc.
- Sun Pharmaceutical Industries Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Fibromyalgia Treatment Market, by Drug Class
1.4.2 Asia Pacific Fibromyalgia Treatment Market, by Distribution Channel
1.4.3 Asia Pacific Fibromyalgia Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Fibromyalgia Treatment Market by Drug Class
3.1 Asia Pacific Anticonvulsants Market by Country
3.2 Asia Pacific Antidepressants Market by Country
3.3 Asia Pacific Muscle Relaxants Market by Country
3.4 Asia Pacific Others Market by Country
Chapter 4. Asia Pacific Fibromyalgia Treatment Market by Distribution Channel
4.1 Asia Pacific Drug stores & Retail Pharmacies Market by Country
4.2 Asia Pacific Hospital Pharmacies Market by Country
4.3 Asia Pacific Online Providers Market by Country
Chapter 5. Asia Pacific Fibromyalgia Treatment Market by Country
5.1 China Fibromyalgia Treatment Market
5.1.1 China Fibromyalgia Treatment Market by Drug Class
5.1.2 China Fibromyalgia Treatment Market by Distribution Channel
5.2 Japan Fibromyalgia Treatment Market
5.2.1 Japan Fibromyalgia Treatment Market by Drug Class
5.2.2 Japan Fibromyalgia Treatment Market by Distribution Channel
5.3 India Fibromyalgia Treatment Market
5.3.1 India Fibromyalgia Treatment Market by Drug Class
5.3.2 India Fibromyalgia Treatment Market by Distribution Channel
5.4 South Korea Fibromyalgia Treatment Market
5.4.1 South Korea Fibromyalgia Treatment Market by Drug Class
5.4.2 South Korea Fibromyalgia Treatment Market by Distribution Channel
5.5 Singapore Fibromyalgia Treatment Market
5.5.1 Singapore Fibromyalgia Treatment Market by Drug Class
5.5.2 Singapore Fibromyalgia Treatment Market by Distribution Channel
5.6 Malaysia Fibromyalgia Treatment Market
5.6.1 Malaysia Fibromyalgia Treatment Market by Drug Class
5.6.2 Malaysia Fibromyalgia Treatment Market by Distribution Channel
5.7 Rest of Asia Pacific Fibromyalgia Treatment Market
5.7.1 Rest of Asia Pacific Fibromyalgia Treatment Market by Drug Class
5.7.2 Rest of Asia Pacific Fibromyalgia Treatment Market by Distribution Channel
Chapter 6. Company Profiles
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 SWOT Analysis
6.2 AbbVie, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Acquisition and Mergers:
6.3 Novartis AG
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Acquisition and Mergers:
6.4 Eli Lilly And Company
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expenses
6.5 Amneal Pharmaceuticals, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental Analysis
6.5.4 Research & Development Expenses
6.6 Teva Pharmaceutical Industries Ltd.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expenses
6.7 Zydus Lifesciences Ltd.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Trials and Approvals:
6.8 Lupin Limited
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Recent strategies and developments:
6.8.3.1 Trials and Approvals:
6.9 Viatris, Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental Analysis
6.9.4 Research & Development Expense
6.10. Sun Pharmaceutical Industries Ltd.
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Regional Analysis
6.10.4 Research & Development Expenses
TABLE 1 Asia Pacific Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 3 Asia Pacific Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 4 Asia Pacific Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 5 Asia Pacific Anticonvulsants Market by Country, 2019 - 2022, USD Million
TABLE 6 Asia Pacific Anticonvulsants Market by Country, 2023 - 2030, USD Million
TABLE 7 Asia Pacific Antidepressants Market by Country, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Antidepressants Market by Country, 2023 - 2030, USD Million
TABLE 9 Asia Pacific Muscle Relaxants Market by Country, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Muscle Relaxants Market by Country, 2023 - 2030, USD Million
TABLE 11 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 13 Asia Pacific Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 15 Asia Pacific Drug stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Drug stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 17 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 18 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 19 Asia Pacific Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Online Providers Market by Country, 2023 - 2030, USD Million
TABLE 21 Asia Pacific Fibromyalgia Treatment Market by Country, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Fibromyalgia Treatment Market by Country, 2023 - 2030, USD Million
TABLE 23 China Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 24 China Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 25 China Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 26 China Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 27 China Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 28 China Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 29 Japan Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 30 Japan Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 31 Japan Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 32 Japan Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 33 Japan Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 34 Japan Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 35 India Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 36 India Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 37 India Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 38 India Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 39 India Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 40 India Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 41 South Korea Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 42 South Korea Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 43 South Korea Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 44 South Korea Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 45 South Korea Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 46 South Korea Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 47 Singapore Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 48 Singapore Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 49 Singapore Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 50 Singapore Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 51 Singapore Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 52 Singapore Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 53 Malaysia Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 54 Malaysia Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 55 Malaysia Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 56 Malaysia Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 57 Malaysia Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 58 Malaysia Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 59 Rest of Asia Pacific Fibromyalgia Treatment Market, 2019 - 2022, USD Million
TABLE 60 Rest of Asia Pacific Fibromyalgia Treatment Market, 2023 - 2030, USD Million
TABLE 61 Rest of Asia Pacific Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 62 Rest of Asia Pacific Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
TABLE 63 Rest of Asia Pacific Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 64 Rest of Asia Pacific Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 65 Key Information – Abbott Laboratories
TABLE 66 Key information – AbbVie, Inc.
TABLE 67 Key Information – Novartis AG
TABLE 68 Key Information – Eli Lilly And Company
TABLE 69 Key Information – Amneal Pharmaceuticals, INc.
TABLE 70 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 71 Key Information – Zydus Lifesciences Ltd.
TABLE 72 Key Information – Lupin Limited
TABLE 73 key information – Viatris, Inc.
TABLE 74 Key Information – Sun Pharmaceutical Industries Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Fibromyalgia Treatment Market share by Drug Class, 2022
FIG 3 Asia Pacific Fibromyalgia Treatment Market share by Drug Class, 2030
FIG 4 Asia Pacific Fibromyalgia Treatment Market by Drug Class, 2019 - 2030, USD Million
FIG 5 Asia Pacific Fibromyalgia Treatment Market share by Distribution Channel, 2022
FIG 6 Asia Pacific Fibromyalgia Treatment Market share by Distribution Channel, 2030
FIG 7 Asia Pacific Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2030, USD Million
FIG 8 Asia Pacific Fibromyalgia Treatment Market share by Country, 2022
FIG 9 Asia Pacific Fibromyalgia Treatment Market share by Country, 2030
FIG 10 Asia Pacific Fibromyalgia Treatment Market by Country, 2019 - 2030, USD Million
FIG 11 Swot analysis: Abbott laboratories